Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Alejandra Melgarejo-Ortuño"'
Autor:
Juan Carlos Nieto-González, Laura Trives-Folguera, Alejandra Melgarejo-Ortuño, Aranzazu Ais, Belén Serrano-Benavente, María Sanjurjo, José María Álvaro-Gracia, Indalecio Monteagudo Sáez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Abstract Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disease that often requires biological therapy to control its activity. Medication persistence and adherence are important aspects on which we have scarce information. We performe
Externí odkaz:
https://doaj.org/article/2d8239bb0ae3444ea771d572512aa78a
Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease
Publikováno v:
Pharmaceutics, Vol 13, Iss 11, p 1786 (2021)
The use of biological drugs has improved outcomes in pediatric inflammatory bowel disease (IBD). Prediction of the response to biological drugs would be extremely useful in IBD, and even more so in children, who are still growing physically and psych
Externí odkaz:
https://doaj.org/article/b275a7c3d7d14dff9e7bd172375fb3fe
Autor:
Alejandra Melgarejo-Ortuño, Jaime Zorrila-Ortúzar, Almudena Ribed-Sánchez, Alvaro Gimenez-Manzorro, María Sanjurjo-Sáez
Publikováno v:
Cirugía Española. 99:68-70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6e74179ce99e842fffde3ee04e9dc42
https://doi.org/10.1016/j.ciresp.2020.02.004
https://doi.org/10.1016/j.ciresp.2020.02.004
Autor:
María Sanjurjo-Sáez, Alvaro Gimenez-Manzorro, Almudena Ribed-Sánchez, Jaime Zorrila-Ortúzar, Alejandra Melgarejo-Ortuño
Publikováno v:
Cirugía Española (English Edition). 99:68-70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66cdc64014608f66afc9e0321c561e9d
https://doi.org/10.1016/j.cireng.2020.02.013
https://doi.org/10.1016/j.cireng.2020.02.013
Autor:
Laura Trives-Folguera, María Sanjurjo, Juan Carlos Nieto-González, Belén Serrano-Benavente, José María Álvaro-Gracia, Alejandra Melgarejo-Ortuño, Aranzazu Ais, Indalecio Monteagudo Sáez
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
BackgroundJuvenile Idiopathic Arthritis (JIA) is a chronic inflammatory disease that often requires the use of biological therapies to control disease activity. Persistence and adherence to treatment are important aspects on which we have scarce info
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e92966d500b2c51591d27e80fbfe0bd1
https://pubmed.ncbi.nlm.nih.gov/34376702
https://pubmed.ncbi.nlm.nih.gov/34376702
Autor:
RM Romero Jiménez, ME Lobato Matilla, S García Sánchez, M Sanjurjo Sáez, Á Narrillos Moraza, A Herranz Alonso, A. Ais Larisgoitia, Alejandra Melgarejo-Ortuño, E Chamorro de Vega
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Patients with immune mediated inflammatory diseases (IMID) have complex treatment. This is due to biological treatments, other chronic treatments, such as immunosuppressors, and the high load of treatments. Aim and objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1505c56d60c5b683519f0bf928c2b5dc
https://doi.org/10.1136/ejhpharm-2021-eahpconf.161
https://doi.org/10.1136/ejhpharm-2021-eahpconf.161
Autor:
Francisco Tejerina, Cristina Villanueva-Bueno, Alvaro Gimenez-Manzorro, Alejandra Melgarejo-Ortuño, Juan Vicente-Valor, Alvaro Narrillos-Moraza, Ana Herranz, María Olmedo, Beatriz Torroba-Sanz, Silvia Manrique-Rodríguez, Miguel Ángel Amor-García, Esther Chamorro-de-Vega, Emilio Bouza, María Sanjurjo, Maricela Valerio, Vicente Escudero-Vilaplana, Marina Machado, Carmen Guadalupe Rodríguez-González, Patricia Muñoz, Milagros Sancho-Gonzalez
Publikováno v:
International Journal of Antimicrobial Agents
Highlights • Few large series have described the clinical characteristics, treatments, costs and outcomes of COVID-19 patients in western countries. • We report our experience with the first 1,255 cases who received anti-COVID-19 treatment at a S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b63e690ff6d4d00dfe57545d208893e
https://pubmed.ncbi.nlm.nih.gov/33259918
https://pubmed.ncbi.nlm.nih.gov/33259918
Autor:
FJ García-Moreno, Roberto Collado-Borrell, María Sanjurjo-Sáez, A Ribed-Sánchez, S García-Sánchez, Vicente Escudero-Vilaplana, Ana Herranz-Alonso, Alejandra Melgarejo-Ortuño, Má Amor, P Ruiz-Briones, Á Narrillos-Moraza
Publikováno v:
Section 1: Introductory Statements and Governance.
Background and importance The large number of health apps for genitourinary cancers means a transparent and objective evaluation by app experts and healthcare professionals is needed. Aim and objectives To analyse the quality of apps for patients dia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5aaba6889e1f71553b897453cbb0a98
https://doi.org/10.1136/ejhpharm-2020-eahpconf.13
https://doi.org/10.1136/ejhpharm-2020-eahpconf.13
Autor:
A Ribed-Sánchez, Alvaro Gimenez-Manzorro, Ana Herranz-Alonso, Á Narrillos-Moraza, A García-García, MA Amor-Garcia, S García-Sánchez, María Sanjurjo-Sáez, Alejandra Melgarejo-Ortuño, FJ García-Moreno, ML Bermejo-Albares
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Operating rooms (OR) are an area with a significant proportion of high risk, high alert medications. A new law was passed in 2016 in Spain with the objective of improving safety regarding drug identification in the OR and de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3dda501984b089ea64c1fdea71c5b329
https://doi.org/10.1136/ejhpharm-2020-eahpconf.387
https://doi.org/10.1136/ejhpharm-2020-eahpconf.387
Autor:
I Herrero-Durán, MJ Aparicio Hernández-Lastras, María Sanjurjo-Sáez, A Ribed-Sánchez, FJ García-Moreno, Ana Herranz-Alonso, MA Amor-Garcia, Alejandra Melgarejo-Ortuño, Á Narrillos-Moraza, S García Sánchez, P Ruiz-Briones
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Intravitreal ranibizumab (IVR) and aflibercept (IVA) are approved for ophthalmology pathologies such as age related macular degeneration (AMD) and diabetic macular oedema (DME). Due to drug costs and high prevalence rates, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9090559d4854a65c35bffb14f409ddf7
https://doi.org/10.1136/ejhpharm-2020-eahpconf.248
https://doi.org/10.1136/ejhpharm-2020-eahpconf.248